Adrian Kruit

728 total citations
17 papers, 549 citations indexed

About

Adrian Kruit is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Adrian Kruit has authored 17 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Physiology. Recurrent topics in Adrian Kruit's work include Sarcoidosis and Beryllium Toxicity Research (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Adrian Kruit is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Adrian Kruit collaborates with scholars based in Netherlands, Canada and Germany. Adrian Kruit's co-authors include Jan C. Grutters, Henk J.T. Ruven, Jules M.M. van den Bosch, Coline H.M. van Moorsel, Pieter Zanen, Wim B. Gerritsen, Michiel Heron, N.M. Korthagen, Nicole P. Barlo and Ralf Weiskirchen and has published in prestigious journals such as CHEST Journal, Clinica Chimica Acta and American Journal of Respiratory Cell and Molecular Biology.

In The Last Decade

Adrian Kruit

17 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrian Kruit Netherlands 13 269 189 143 74 63 17 549
Peter R. Studdy United Kingdom 10 285 1.1× 242 1.3× 149 1.0× 60 0.8× 28 0.4× 12 656
Zhe Zhou China 13 488 1.8× 104 0.6× 207 1.4× 46 0.6× 42 0.7× 44 805
Motoyoshi Suzuki Japan 14 193 0.7× 123 0.7× 431 3.0× 21 0.3× 40 0.6× 30 801
Emiko Ono Japan 17 405 1.5× 533 2.8× 87 0.6× 31 0.4× 20 0.3× 47 993
Hideaki Yamasawa Japan 15 356 1.3× 188 1.0× 96 0.7× 28 0.4× 7 0.1× 52 632
W A McAllister United Kingdom 8 154 0.6× 111 0.6× 85 0.6× 74 1.0× 45 0.7× 11 496
Ae-Rin Baek South Korea 13 306 1.1× 111 0.6× 156 1.1× 28 0.4× 12 0.2× 41 613
Dale R. Bachwich United States 8 113 0.4× 127 0.7× 110 0.8× 20 0.3× 19 0.3× 15 686
Keiko Nakao Japan 15 293 1.1× 75 0.4× 92 0.6× 18 0.2× 44 0.7× 33 571
Irith Weissman Israel 9 169 0.6× 61 0.3× 178 1.2× 34 0.5× 13 0.2× 13 563

Countries citing papers authored by Adrian Kruit

Since Specialization
Citations

This map shows the geographic impact of Adrian Kruit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Kruit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Kruit more than expected).

Fields of papers citing papers by Adrian Kruit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Kruit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Kruit. The network helps show where Adrian Kruit may publish in the future.

Co-authorship network of co-authors of Adrian Kruit

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Kruit. A scholar is included among the top collaborators of Adrian Kruit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Kruit. Adrian Kruit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kruit, Adrian & Pieter Zanen. (2016). The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseases. Clinical Biochemistry. 49(7-8). 534–537. 42 indexed citations
2.
Heijboer, Annemieke C., et al.. (2016). Inaccurate First-Generation Testosterone Assays Are Influenced by Sex Hormone–Binding Globulin Concentrations. The Journal of Applied Laboratory Medicine. 1(2). 194–201. 14 indexed citations
3.
Büttler, Rahel M., Adrian Kruit, Marinus A. Blankenstein, & Annemieke C. Heijboer. (2013). Measurement of dehydroepiandrosterone sulphate (DHEAS): A comparison of Isotope-Dilution Liquid Chromatography Tandem Mass Spectrometry (ID-LC-MS/MS) and seven currently available immunoassays. Clinica Chimica Acta. 424. 22–26. 27 indexed citations
4.
Kruit, Adrian, et al.. (2012). Prothrombin complex concentrate for the urgent reversal of warfarin. Assessment of a standard dosing protocol. Transfusion and Apheresis Science. 46(3). 309–314. 19 indexed citations
5.
Korthagen, N.M., Coline H.M. van Moorsel, Nicole P. Barlo, et al.. (2010). Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis. Respiratory Medicine. 105(1). 106–113. 94 indexed citations
6.
Kruit, Adrian, et al.. (2010). CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases.. PubMed. 27(2). 138–46. 35 indexed citations
7.
Kruit, Adrian, et al.. (2010). Angiotensin II receptor type 1 1166 A/C and angiotensin converting enzyme I/D gene polymorphisms in a Dutch sarcoidosis cohort.. PubMed. 27(2). 147–52. 11 indexed citations
8.
Rudež, Goran, Heleen Bouman, Jochem W. van Werkum, et al.. (2009). Common Variation in the Platelet Receptor P2RY12 Gene Is Associated With Residual On-Clopidogrel Platelet Reactivity in Patients Undergoing Elective Percutaneous Coronary Interventions. Circulation Cardiovascular Genetics. 2(5). 515–521. 41 indexed citations
9.
Kruit, Adrian, Madeleine M.A. Tilanus‐Linthorst, Joke G. Boonstra, et al.. (2008). MUC1 568 A/G genotype-dependent Cancer Antigen 15-3 levels in breast cancer patients. Clinical Biochemistry. 42(7-8). 662–665. 3 indexed citations
10.
Kruit, Adrian, et al.. (2007). A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respiratory Medicine. 101(7). 1563–1571. 59 indexed citations
11.
Kruit, Adrian, Jan C. Grutters, Wim B. Gerritsen, et al.. (2006). ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respiratory Medicine. 101(3). 510–515. 65 indexed citations
12.
Kruit, Adrian, Jan C. Grutters, Henk J.T. Ruven, et al.. (2006). Chymase Gene <i>(CMA1)</i> Polymorphisms in Dutch and Japanese Sarcoidosis Patients. Respiration. 73(5). 623–633. 5 indexed citations
13.
Kruit, Adrian, Jan C. Grutters, Henk J.T. Ruven, et al.. (2006). Transforming Growth Factor-β Gene Polymorphisms in Sarcoidosis Patients With and Without Fibrosis. CHEST Journal. 129(6). 1584–1591. 75 indexed citations
14.
Janssen, Rob, Adrian Kruit, Jan C. Grutters, et al.. (2005). The Mucin-1 568 Adenosine to Guanine Polymorphism Influences Serum Krebs von den Lungen-6 levels. American Journal of Respiratory Cell and Molecular Biology. 34(4). 496–499. 25 indexed citations
15.
Kruit, Adrian, Henk J.T. Ruven, Jan C. Grutters, & Jules M.M. van den Bosch. (2005). Angiotensin-converting enzyme 2 (ACE2) haplotypes are associated with pulmonary disease phenotypes in sarcoidosis patients.. PubMed. 22(3). 195–203. 8 indexed citations
16.
Kruit, Adrian, Carlos Reyes‐Moreno, Donald W. W. Newling, Albert A. Geldof, & Michael Koutsilieris. (2000). Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicin.. PubMed. 19(4B). 3153–6. 12 indexed citations
17.
Geldof, Albert A., Adrian Kruit, Don Newling, & Ben J. Slotman. (1999). Synergism between cisplatin and radiotherapy in an in vitro prostate tumor cell line.. PubMed. 19(1A). 505–8. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026